Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI
1 clinical trials · Condition
◉ Watch Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI
| Record | Firm | Date |
|---|---|---|
| A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy (NCT03754764) | Chinese PLA General Hospital | 2018-11-23 |
Track Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI automatically
Every clearance here is in the API, with alerts when new ones post.